These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 19703301

  • 21. A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.
    Little JL, Serzhanova V, Izumchenko E, Egleston BL, Parise E, Klein-Szanto AJ, Loudon G, Shubina M, Seo S, Kurokawa M, Ochs MF, Golemis EA.
    Oncogene; 2014 Jan 23; 33(4):411-20. PubMed ID: 23318423
    [Abstract] [Full Text] [Related]

  • 22. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E.
    Cancer Res; 2007 Sep 15; 67(18):8671-81. PubMed ID: 17875707
    [Abstract] [Full Text] [Related]

  • 23. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
    Lenferink AE, Simpson JF, Shawver LK, Coffey RJ, Forbes JT, Arteaga CL.
    Proc Natl Acad Sci U S A; 2000 Aug 15; 97(17):9609-14. PubMed ID: 10931950
    [Abstract] [Full Text] [Related]

  • 24. A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas.
    Taverna D, Crowley D, Connolly M, Bronson RT, Hynes RO.
    Cancer Res; 2005 Nov 15; 65(22):10324-9. PubMed ID: 16288021
    [Abstract] [Full Text] [Related]

  • 25. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
    Basak P, Leslie H, Dillon RL, Muller WJ, Raouf A, Mowat MRA.
    Genes Chromosomes Cancer; 2018 Apr 15; 57(4):182-191. PubMed ID: 29218825
    [Abstract] [Full Text] [Related]

  • 26. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
    Wellberg EA, Rudolph MC, Lewis AS, Padilla-Just N, Jedlicka P, Anderson SM.
    Breast Cancer Res; 2014 Dec 04; 16(6):481. PubMed ID: 25472762
    [Abstract] [Full Text] [Related]

  • 27. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.
    Denzel MS, Hebbard LW, Shostak G, Shapiro L, Cardiff RD, Ranscht B.
    Clin Cancer Res; 2009 May 15; 15(10):3256-64. PubMed ID: 19447866
    [Abstract] [Full Text] [Related]

  • 28. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
    Zhou H, Chen WD, Qin X, Lee K, Liu L, Markowitz SD, Gerson SL.
    Oncogene; 2001 Sep 20; 20(42):6009-17. PubMed ID: 11593408
    [Abstract] [Full Text] [Related]

  • 29. Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.
    Wong AW, Dunlap SM, Holcomb VB, Nunez NP.
    Alcohol Clin Exp Res; 2012 Apr 20; 36(4):577-87. PubMed ID: 21981381
    [Abstract] [Full Text] [Related]

  • 30. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
    Novitskiy SV, Forrester E, Pickup MW, Gorska AE, Chytil A, Aakre M, Polosukhina D, Owens P, Yusupova DR, Zhao Z, Ye F, Shyr Y, Moses HL.
    Breast Cancer Res; 2014 Oct 04; 16(5):425. PubMed ID: 25280532
    [Abstract] [Full Text] [Related]

  • 31. Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP.
    Singhal J, Kulkarni P, Horne D, Awasthi S, Salgia R, Singhal SS.
    Mol Carcinog; 2021 Mar 04; 60(3):213-223. PubMed ID: 33544936
    [Abstract] [Full Text] [Related]

  • 32. Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.
    Decock J, Hendrickx W, Thirkettle S, Gutiérrez-Fernández A, Robinson SD, Edwards DR.
    Breast Cancer Res; 2015 Mar 14; 17(1):38. PubMed ID: 25848906
    [Abstract] [Full Text] [Related]

  • 33. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
    Hewitt SC, Bocchinfuso WP, Zhai J, Harrell C, Koonce L, Clark J, Myers P, Korach KS.
    Cancer Res; 2002 May 15; 62(10):2798-805. PubMed ID: 12019156
    [Abstract] [Full Text] [Related]

  • 34. Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands.
    Han JS, Crowe DL.
    BMC Cancer; 2010 Nov 16; 10():629. PubMed ID: 21080969
    [Abstract] [Full Text] [Related]

  • 35. Haploinsufficiency of the Nijmegen breakage syndrome 1 gene increases mammary tumor latency and metastasis.
    Wan R, Crowe DL.
    Int J Oncol; 2012 Jul 16; 41(1):345-52. PubMed ID: 22576691
    [Abstract] [Full Text] [Related]

  • 36. Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1.
    Muraoka RS, Koh Y, Roebuck LR, Sanders ME, Brantley-Sieders D, Gorska AE, Moses HL, Arteaga CL.
    Mol Cell Biol; 2003 Dec 16; 23(23):8691-703. PubMed ID: 14612410
    [Abstract] [Full Text] [Related]

  • 37. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas.
    Schroeder JA, Adriance MC, McConnell EJ, Thompson MC, Pockaj B, Gendler SJ.
    J Biol Chem; 2002 Jun 21; 277(25):22692-8. PubMed ID: 11950845
    [Abstract] [Full Text] [Related]

  • 38. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
    Jacquemart IC, Springs AE, Chen WY.
    Int J Oncol; 2009 Feb 21; 34(2):517-28. PubMed ID: 19148488
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.
    Davis VL, Shaikh F, Gallagher KM, Villegas M, Rea SL, Cline JM, Hughes CL.
    Horm Cancer; 2012 Dec 21; 3(5-6):227-39. PubMed ID: 22968785
    [Abstract] [Full Text] [Related]

  • 40. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS.
    Exp Mol Pathol; 2001 Jun 21; 70(3):183-93. PubMed ID: 11417997
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.